SEPTEMBER 27, 2018
7:30
Registration and Continental Breakfast
8:15
Chairperson’s Welcome and Opening Remarks
Sabrina Yohai
Vice President, Policy, Access & Value, Corporate Legal
Vertex Pharmaceuticals Inc.
8:30
State Drug Pricing Reporting Requirements and Interpretations —
What You Need to Know Now to Ensure Reporting Compliance
Trevor L. Wear
Partner
Sidley Austin LLP
9:30
Federal Legislative Activity — American Patients First Update
Seth Lundy
Partner
King & Spalding LLP
10:15
Implications of State Drug Pricing Transparency Laws on Policy
MODERATOR:
Vince Sampson
Partner
Cooley LLP
PANELISTS:
Joanne Chan
Assistant General Counsel
Pharmaceutical Research and Manufacturers of America (PhRMA)
Kendra Martello
Senior Director, Public Policy, Government Affairs & Public Policy
Mallinckrodt Pharmaceuticals
11:15
Networking and Refreshment Break
11:45
California SB-17 — Implementation and Enforcement Update
Sarah diFrancesca
Partner
Cooley LLP
12:15
Oregon HB 4005 — Reporting Requirements Overview and Update
Trevor L. Wear
Partner
Sidley Austin LLP
12:45
Networking Luncheon
1:30
Operational Best Practices Focused on Governance and Planning for the Future
Andrew Parks
Director
KPMG
2:15
PANEL DISCUSSION:The Impact of Transparency and Disclosure Legislation on Legal and Compliance Practices
MODERATOR:
Brian A. Bohnenkamp
Partner, FDA & Life Sciences Practice
King & Spalding LLP
PANELISTS:
Debbie A. Walters
Vice President, Assistant General Counsel
Pfizer Inc
Sabrina Yohai
Vice President, Policy, Access & Value, Corporate Legal
Vertex Pharmaceuticals Inc.
3:15
Networking and Refreshment Break
3:45
The Latest Developments for New York’s Medicaid Drug Cap and the Impact of ICER on Drug Pricing
Jonathan Connell, JD, MBA
Senior Counsel
Bristol-Myers Squibb
4:30
Chairperson’s Closing Remarks
4:45
Close of Conference
Networking, Wine and Cheese Reception
Immediately following the final session
SEPTEMBER 27, 2018
7:30
Registration and Continental Breakfast
8:15
Chairperson’s Welcome and Opening Remarks
Sabrina Yohai
Vice President, Policy, Access & Value, Corporate Legal
Vertex Pharmaceuticals Inc.
8:30
State Drug Pricing Reporting Requirements and Interpretations —
What You Need to Know Now to Ensure Reporting Compliance
Trevor L. Wear
Partner
Sidley Austin LLP
9:30
Federal Legislative Activity — American Patients First Update
Seth Lundy
Partner
King & Spalding LLP
10:15
Implications of State Drug Pricing Transparency Laws on Policy
MODERATOR:
Vince Sampson
Partner
Cooley LLP
PANELISTS:
Joanne Chan
Assistant General Counsel
Pharmaceutical Research and Manufacturers of America (PhRMA)
Kendra Martello
Senior Director, Public Policy, Government Affairs & Public Policy
Mallinckrodt Pharmaceuticals
11:15
Networking and Refreshment Break
11:45
California SB-17 — Implementation and Enforcement Update
Sarah diFrancesca
Partner
Cooley LLP
12:15
Oregon HB 4005 — Reporting Requirements Overview and Update
Trevor L. Wear
Partner
Sidley Austin LLP
12:45
Networking Luncheon
1:30
Operational Best Practices Focused on Governance and Planning for the Future
Andrew Parks
Director
KPMG
2:15
PANEL DISCUSSION:The Impact of Transparency and Disclosure Legislation on Legal and Compliance Practices
MODERATOR:
Brian A. Bohnenkamp
Partner, FDA & Life Sciences Practice
King & Spalding LLP
PANELISTS:
Debbie A. Walters
Vice President, Assistant General Counsel
Pfizer Inc
Sabrina Yohai
Vice President, Policy, Access & Value, Corporate Legal
Vertex Pharmaceuticals Inc.
3:15
Networking and Refreshment Break
3:45
The Latest Developments for New York’s Medicaid Drug Cap and the Impact of ICER on Drug Pricing
Jonathan Connell, JD, MBA
Senior Counsel
Bristol-Myers Squibb
4:30
Chairperson’s Closing Remarks
4:45
Close of Conference
Networking, Wine and Cheese Reception
Immediately following the final session